Description
Henry Schein’s $3.4 Billion Quarter: Dental Resilience Meets Software Momentum!
Henry Schein, Inc. reported financial results for the first quarter of 2026 that reflect a combination of ongoing market strengths and operational initiatives, alongside certain industry headwinds. Global sales reached $3.4 billion, marking a 6.3% increase over the previous year, supported by internal growth of 2.5%, favorable currency impacts, and contributions from acquisitions. The company’s performance demonstrated resilience in dental markets, with U.S. dental merchandise sales growing 5.6% and equipment sales increasing 3.4%, driven significantly by investments from dental service organizations (DSOs). International dental sales also contributed positively, particularly from markets such as the U.K., Italy, Brazil, Germany, Canada, Australia, and New Zealand. Within Henry Schein’s medical segment, growth was more moderate at 1.3%, impacted by a decline in demand for point-of-care diagnostic tests related to respiratory illnesses stemming from a light flu season. Nonetheless, underlying demand in non-acute care settings and expansion in Home Solutions provided offsetting momentum.
